Binding Site Information of Target
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T86254 | Target Info | |||
| Target Name | Tenascin (TNC) | ||||
| Synonyms | Tenascin-C; TN-C; TN; Neuronectin; Myotendinous antigen; Miotendinous antigen; JI; Hexabrachion; HXB; Glioma-associated-extracellular matrix antigen; GP 150-225; GMEM; Cytotactin | ||||
| Target Type | Clinical trial Target | ||||
| Gene Name | TNC | ||||
| UniProt ID | |||||
| Drug Binding Sites of Target | Top | |||||
|---|---|---|---|---|---|---|
| Ligand Name: 1-(3-Methyl-1,2,4-thiadiazol-5-yl)-1,4-diazepane | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1578665941 | PDB:5R61 | ||||
| Method | X-ray diffraction | Resolution | 1.38 Å | Mutation | No | [1] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
|
||||||
| Ligand Name: 4-(4-Methylpiperazin-1-yl)benzonitrile | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434840 | PDB:5R62 | ||||
| Method | X-ray diffraction | Resolution | 1.40 Å | Mutation | No | [2] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
|
||||||
| Ligand Name: (2S)-N-(3-chloro-2-methylphenyl)oxolane-2-carboxamide | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1545312521 | PDB:5R5U | ||||
| Method | X-ray diffraction | Resolution | 1.52 Å | Mutation | No | [3] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NTV or .NTV2 or .NTV3 or :3NTV;style chemicals stick;color identity;select .A:2010 or .A:2045 or .A:2046 or .A:2047 or .A:2048 or .A:2050 or .A:2054 or .A:2055 or .A:2056 or .A:2060; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: 1-(5-Methyl-1,3,4-thiadiazol-2-yl)piperidine | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1251207602 | PDB:5R5T | ||||
| Method | X-ray diffraction | Resolution | 1.55 Å | Mutation | No | [4] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .RWS or .RWS2 or .RWS3 or :3RWS;style chemicals stick;color identity;select .A:2019 or .A:2073 or .A:2084 or .A:2086 or .A:2107 or .A:2192; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: {1-[(2-Methyl-1,3-thiazol-4-yl)methyl]piperidin-4-yl}methanamine | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1259335913 | PDB:5R5X | ||||
| Method | X-ray diffraction | Resolution | 1.56 Å | Mutation | No | [5] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .RWV or .RWV2 or .RWV3 or :3RWV;style chemicals stick;color identity;select .A:2010 or .A:2045 or .A:2046 or .A:2047 or .A:2048 or .A:2050 or .A:2054 or .A:2055 or .A:2056 or .A:2057 or .A:2060; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z509756472 | PDB:5R5Y | ||||
| Method | X-ray diffraction | Resolution | 1.57 Å | Mutation | No | [6] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .JGG or .JGG2 or .JGG3 or :3JGG;style chemicals stick;color identity;select .A:2011 or .A:2025 or .A:2045 or .A:2046 or .A:2047 or .A:2048 or .A:2049 or .A:2050 or .A:2054 or .A:2055 or .A:2056; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: 3-[(2-methyl-1H-imidazol-1-yl)methyl]benzonitrile | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z319545618 | PDB:5R63 | ||||
| Method | X-ray diffraction | Resolution | 1.59 Å | Mutation | No | [7] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .RXS or .RXS2 or .RXS3 or :3RXS;style chemicals stick;color identity;select .A:2011 or .A:2045 or .A:2046 or .A:2047 or .A:2048 or .A:2049 or .A:2050 or .A:2054 or .A:2055 or .A:2056 or .A:2060; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: N-(4-fluorophenyl)-2-pyrrolidin-1-ylacetamide | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434942 | PDB:5R5W | ||||
| Method | X-ray diffraction | Resolution | 1.60 Å | Mutation | No | [8] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .EJQ or .EJQ2 or .EJQ3 or :3EJQ;style chemicals stick;color identity;select .A:2045 or .A:2046 or .A:2047 or .A:2048 or .A:2049 or .A:2050 or .A:2054 or .A:2055 or .A:2056; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: 2-Methyl-2-{[(3-methylthiophen-2-YL)methyl]amino}propan-1-OL | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434821 | PDB:5R5Z | ||||
| Method | X-ray diffraction | Resolution | 1.67 Å | Mutation | No | [9] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .RX7 or .RX72 or .RX73 or :3RX7;style chemicals stick;color identity;select .A:2069 or .A:2071 or .A:2086 or .A:2087 or .A:2088 or .A:2105 or .A:2106 or .A:2107 or .A:2189; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: 1-(4-fluorophenyl)-~{N}-[[(2~{R})-oxolan-2-yl]methyl]methanamine | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434824 | PDB:5R5V | ||||
| Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | No | [10] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .AXS or .AXS2 or .AXS3 or :3AXS;style chemicals stick;color identity;select .A:2045 or .A:2046 or .A:2047 or .A:2048 or .A:2049 or .A:2050 or .A:2054 or .A:2055 or .A:2056 or .A:2060; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: 2-(4-fluorophenoxy)-1-(1H-pyrrol-1-yl)ethan-1-one | Ligand Info | |||||
| Structure Description | PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z19735067 | PDB:5R60 | ||||
| Method | X-ray diffraction | Resolution | 1.79 Å | Mutation | No | [11] |
| PDB Sequence |
SMPFPKDCSQ
1986 AMLNGDTTSG1996 LYTIYLNGDK2006 AQALEVFCDM2016 TSDGGGWIVF2026 LRRKNGRENF 2036 YQNWKAYAAG2046 FGDRREEFWL2056 GLDNLNKITA2066 QGQYELRVDL2076 RDHGETAFAV 2086 YDKFSVGDAK2096 TRYKLKVEGY2106 SGTAGDSMAY2116 HNGRSFSTFD2126 KNCALSYKGA 2143 FWYRNCHRVN2153 LMGRYGDNNH2163 SQGVNWFHWK2173 GHEHSIQFAE2183 MKLRPSNFRN 2193 L
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .RXG or .RXG2 or .RXG3 or :3RXG;style chemicals stick;color identity;select .A:2045 or .A:2046 or .A:2047 or .A:2048 or .A:2049 or .A:2050 or .A:2054 or .A:2055 or .A:2056 or .A:2060; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | PanDDA analysis group deposition | ||||
| REF 2 | PanDDA analysis group deposition | ||||
| REF 3 | PanDDA analysis group deposition | ||||
| REF 4 | PanDDA analysis group deposition | ||||
| REF 5 | PanDDA analysis group deposition | ||||
| REF 6 | PanDDA analysis group deposition | ||||
| REF 7 | PanDDA analysis group deposition | ||||
| REF 8 | PanDDA analysis group deposition | ||||
| REF 9 | PanDDA analysis group deposition | ||||
| REF 10 | PanDDA analysis group deposition | ||||
| REF 11 | PanDDA analysis group deposition | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.